Back to Directory
Insulin Aspart
Performance & EnduranceRapid-acting insulin analog for diabetes management, marketed as NovoLog.
Key Benefits
- ✓Rapid glucose control
- ✓Mealtime insulin coverage
- ✓Fast onset (10-20 min)
- ✓Flexible dosing
- ✓Prevents postprandial spikes
Dosing Information
Dosage Range
Variable
Frequency
With each meal
Typical Duration
Lifelong for T1D
Detailed Protocol
Administered via subcutaneous injection or insulin pump. Dosed based on carbohydrate intake and blood glucose. Taken immediately before or with meals. Prescription required.
About Insulin Aspart
Insulin aspart (NovoLog, Fiasp) is a rapid-acting insulin analog with proline at position B28 replaced by aspartic acid. This modification accelerates absorption. Used for mealtime glucose control in diabetes.
Research Notes
FDA-approved rapid-acting insulin analog. Widely used for mealtime coverage. Fast onset and offset provide flexibility. Standard diabetes care.
Potential Side Effects
- •Hypoglycemia
- •Weight gain
- •Injection site reactions
- •Allergic reactions (rare)
Always consult with a healthcare professional before starting any peptide therapy.